INAB CIK: 1740279

IN8bio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−13.5
FY22:
−24.1
FY23:
−23.3
FY24:
−24.1
FY25:
−12.7
Change from FY21 to FY25
millions USD
FY21:
−0.31
FY22:
−3.71
FY23:
−0.60
FY24:
−0.19
FY25:
0
Change from FY21 to FY25
millions USD
FY21:
33.0
FY22:
8.99
FY23:
27.0
FY24:
14.2
FY25:
28.6
millions USD
FY21:
19.1
FY22:
−18.8
FY23:
3.10
FY24:
−10.2
FY25:
15.9

All amounts in millions USD Data source:SEC EDGAR